Adjuvant therapy for adenocarcinoma of the kidney: present position and prospects.
D000230:Adenocarcinoma / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D000970:Antineoplastic Agents / Q000627:therapeutic use; D006801:Humans; D007167:Immunotherapy; D007680:Kidney Neoplasms / Q000188:drug therapy / Q000532:radiotherapy / Q000601:surgery / Q000628:therapy*; D009362:Neoplasm Metastasis; D009392:Nephrectomy; D009502:Neutrons; D010100:Oxygen / Q000627:therapeutic use; D011372:Progestins / Q000627:therapeutic use; D011829:Radiation Dosage; D013739:Testosterone / Q000627:therapeutic use
D000970:Antineoplastic Agents; D011372:Progestins; D013739:Testosterone; D010100:Oxygen